So let's get into what the weight loss looked like in this first trial, because there are longer obesity trials where, where the primary outcome is the weight loss this was again a specific trial in measuring pain reduction in folks with osteoarthritis of the knee but check out these numbers these are placebo adjusted meaning it's taking the two percent out that people lost on placebo but looking at these numbers Folks on one milligram over forty eight weeks lost seventeen percent
In addition to metabolizing bilirubin and certain anti-cancer drugs in the liver, the alpha class of these enzymes exhibit glutathione peroxidase activity, thereby protecting the cells from reactive oxygen species and the products of peroxidation
[8] [9] Common Gastrointestinal Side Effects Explained Nausea, diarrhoea, vomiting, and constipation are the most common gastrointestinal side effects of retatrutide, reported in up to 60% of Phase 2 trial participants and increasing with higher doses
Retrieved on July 26, 2026 from MLA Stoakes, Shelley Farrar
Applications: Weight management therapies requiring a safe, non-hormonal approach
However, it can take time for your body to adjust to the medication